top of page
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
Response to the Nature article: Moving from prison to PhD
There are fewer than ten empirical studies on the transition from prison to university so the article “Moving from Prison to PhD” is a...
Drug Science
Nov 20, 20193 min read
Response to the NICE recommendations
The National Institute for Health and Care Excellence (NICE) published their guidance to clinicians on the 11th of November 2019...
Drug Science
Nov 11, 20192 min read
Drug policy in UK has regressed in past decade, says former chief adviser
On the 30th of October 2019, our Founder – Professor David Nutt spoke at the Centre for Crime and Justice Studies with Professor Alex...
Drug Science
Nov 4, 20192 min read
New Zealand revises sentencing framework for methamphetamine offences
Dr James Foulds, Consultant forensic psychiatrist, Christchurch New Zealand Methamphetamine smoking is the commonest form of stimulant...
James A Foulds, David Nutt
Oct 23, 20192 min read
De-mythologizing and re-branding of kava as the new ‘world drug’ of choice
Authors: S Apo Aporosa Published: September 19, 2019 What seemed impossible 50 years ago is today becoming a reality as ‘soft drugs’ such...
S Apo Aporosa
Sep 19, 20191 min read
NICE on cannabidiol for childhood epilepsy
At the end of last week, NICE released their initial appraisal on cannabidiol in the form of Epidiolex for childhood epilepsy. As...
Drug Science
Aug 27, 20192 min read
Prof Nutt on the Roots of Cannabis Policy Change
The Roots of Cannabis Policy Change David’s talk will explore the basis of cannabis being a controlled drug with a focus on the political machinations behind the decision to make it illegal in the 1930s. He will then describe the efforts that the charity he set up in 2009 have made to reverse this unevidenced action, and share the plans they have for improving access for UK patients, who have been badly let down by the current intense regulations that followed cannabis being
Professor David Nutt
Aug 8, 20191 min read
State policies in the United States impacting drug-related convictions and their consequences in 2015
Authors: Ryan Cramer, Sarah Hexem, Kelly Thompson, Archana Bodas LaPollo, Harrell W Chesson, Jami S Leichliter Published: July 30, 2019...
Ryan Cramer, Sarah Hexem and more
Jul 30, 20192 min read
Drug Science gives evidence to the Health and Social Care Committee on Medicinal Cannabis
On 1 November 2018, following considerable popular pressure surrounding a select number of young children with treatment-resistant...
Drug Science
May 22, 20196 min read
Drug Science gives evidence to the Health and Social Care Committee drugs policy inquiry
The UK Government Health and Social Committee invited submissions to review the current policy positions in the UK. Read Drug Science’s...
Drug Science
May 14, 20191 min read
The Global Commission on Drug Policy misses the mark
Author: Willem Scholten Published: November 22, 2018 The Global Commission on Drug Policy launched a report on the world drug...
Willem Scholten
Nov 22, 20181 min read
ACMD advice on cannabis-derived medicinal products
On 11 September 2018, the ACMD published its Advice to the Home Secretary and to the Secretary of State for Health and Social Care. It...
Rudi Fortson QC
Sep 11, 20182 min read
Conceptualising a policy framework for the implementation of medical marijuana in the Caribbean territory of Barbados
Authors: Alana DD Griffith, Damian H Cohall Published: September 5, 2018 Unlike the recent global trend of a decline in the prohibition...
Alana Griffith and Damian Cohall
Sep 5, 20181 min read
Class A is no solution to the problem of 'monkey dust'
The recent spate of headlines about the rising use of monkey dust drug in Stoke on Trent has led to calls to it to be made a Class A drug...
Professor David Nutt
Aug 5, 20184 min read
A tale of two moralities: Politicians, doctors, use of addictive substances and lobbying
Alcohol use during the day is common amongst British MPs and Parliamentary staff even when Parliament is in session. MPs are frequently...
Professor David Nutt
Jul 18, 20181 min read
Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policy
The potential of psychedelic drugs in the treatment of mental health problems is increasingly being recognized. However, relatively little t
Drug Science
Jul 26, 20171 min read
WHO and UNDP change in leadership: What views on drug policy and harm reduction?
The UN General Assembly Special Session on drugs held in April 2016 has been organized by the international drug control entities, but...
Drug Science
May 4, 20171 min read
THCv - an abject cop-out from the ACMD, another research opportunity for the UK lost
The cannabis plant produces over 100 compounds with therapeutic potential. Most of these have never been properly studied because of the...
Drug Science
Jan 24, 20174 min read
The 15th anniversary of the Portuguese drug policy: Its history, its success and its future
Fifteen years ago when Portugal decriminalized the consumption of all narcotic drugs and psychotropic substances it was both a bold and a...
Drug Science
Jan 1, 20171 min read
‘Scotch mist’: the ongoing saga of Alcohol Minimum Unit Pricing
‘Scotch mist’ may be taken to refer to a whisky-based beverage (Scotch whisky, crushed ice and lemon peel). More traditionally, the term...
Drug Science
Dec 10, 20166 min read
Better late than never? After 82 years the WHO reviews cannabis!
The WHO is the world’s leading health organisation guiding governments around the world. So we expect their advice to be up to date and...
Drug Science
Dec 10, 20163 min read
bottom of page